Commentary Open Access March 08, 2025

A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole

1
Division of Infectious Diseases and Infection Control, Saitama Medical University, International Medical Center, Hidaka City, Japan
Page(s): 16-18
Received
January 08, 2025
Revised
February 26, 2025
Accepted
March 07, 2025
Published
March 08, 2025
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2025. Published by Scientific Publications
Article metrics
Views
264
Downloads
48

Cite This Article

APA Style
Seki, M. (2025). A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole. Current Research in Public Health, 5(1), 16-18. https://doi.org/10.31586/gjmcr.2025.6019
ACS Style
Seki, M. A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole. Current Research in Public Health 2025 5(1), 16-18. https://doi.org/10.31586/gjmcr.2025.6019
Chicago/Turabian Style
Seki, Masafumi. 2025. "A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole". Current Research in Public Health 5, no. 1: 16-18. https://doi.org/10.31586/gjmcr.2025.6019
AMA Style
Seki M. A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole. Current Research in Public Health. 2025; 5(1):16-18. https://doi.org/10.31586/gjmcr.2025.6019
@Article{crph6019,
AUTHOR = {Seki, Masafumi},
TITLE = {A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole},
JOURNAL = {Current Research in Public Health},
VOLUME = {5},
YEAR = {2025},
NUMBER = {1},
PAGES = {16-18},
URL = {https://www.scipublications.com/journal/index.php/GJMCR/article/view/6019},
ISSN = {2831-5162},
DOI = {10.31586/gjmcr.2025.6019},
ABSTRACT = {Isavuconazole (ISCZ) is a novel antifungal agent that is expected to be effective against severe fungal diseases. A case of chronic pulmonary aspergillosis that was refractory to existing agents, such as micafungin, but was successfully treated by ISCZ, is presented.},
}
%0 Journal Article
%A Seki, Masafumi
%D 2025
%J Current Research in Public Health

%@ 2831-5162
%V 5
%N 1
%P 16-18

%T A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole
%M doi:10.31586/gjmcr.2025.6019
%U https://www.scipublications.com/journal/index.php/GJMCR/article/view/6019
TY  - JOUR
AU  - Seki, Masafumi
TI  - A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole
T2  - Current Research in Public Health
PY  - 2025
VL  - 5
IS  - 1
SN  - 2831-5162
SP  - 16
EP  - 18
UR  - https://www.scipublications.com/journal/index.php/GJMCR/article/view/6019
AB  - Isavuconazole (ISCZ) is a novel antifungal agent that is expected to be effective against severe fungal diseases. A case of chronic pulmonary aspergillosis that was refractory to existing agents, such as micafungin, but was successfully treated by ISCZ, is presented.
DO  - A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole
TI  - 10.31586/gjmcr.2025.6019
ER  -